Pharma Mar S.A.

Sector and Industry

Healthcare, Biopharmaceuticals

Performance (1Y)

4.68%

Market Cap

792.68 Mil.

P/E Ratio

17.41

Dividend Yield

1.08 %

Earnings per Share

4.30 €

Peer Group

Company NameMarket CapRevenue Last Reported YearP/E RatioProfit Growth 1YLast PricePrevious Trading Day Change
Eli Lilly and Company864.54 Bil.57.78 Bil.46.82
+86.88 %
0.00
-
Johnson & Johnson425.70 Bil.83.48 Bil.18.82
+82.71 %
0.00
-
AbbVie Inc.343.94 Bil.54.21 Bil.96.78
-5.29 %
0.00
-
Roche Holding AG286.62 Bil.65.80 Bil.20.72
+58.45 %
0.00
-
AstraZeneca PLC244.91 Bil.52.09 Bil.27.55
+39.41 %
0.00
-
NOVARTIS AG 224.76 Bil.48.44 Bil.18.30
+12.45 %
0.00
-
Merck & Co. Inc.221.79 Bil.57.55 Bil.14.46
+2.25 %
0.00
-
Novo-Nordisk AS B193.52 Bil.41.49 Bil.14.11
+1.54 %
0.00
-
Amgen Inc.150.16 Bil.32.57 Bil.23.01
+80.77 %
0.00
-
Gilead Sciences Inc.129.70 Bil.26.10 Bil.18.10
+1,599.93 %
0.00
-

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE76.35 G0 Units
PRICE DETERMINATION TIME07/21/2026 / 09:56:47 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW76.7574.8
PREV. DAY'S PRICE75.4 (07/20)
CHANGE DAY BEFORE
+0.95
1.26 %
52 WEEK HIGH / LOW105 (05/07)66.25 (06/12)
More Price Information

Key Figures (in EUR)

2023202420252026e2027e
EARNINGS PER SHARE
0.061.494.302.444.66
DIVIDENDS PER SHARE
0.650.800.810.950.96
DIVIDEND YIELD IN %
1.58 %1.00 %1.08 %--
DIVIDEND GROWTH IN %
23.46 %23.08 %1.25 %--
PRICE - EARNINGS RATIO
646.9353.5817.4131.0716.27
PRICE - BOOK RATIO
3.756.735.16--
PRICE - SALES RATIO
4.658.015.90--
PRICE - CASH FLOW RATIO
-232.5324.60--
Further Key Figures

Master Data

WKN
A2P9YT
ISIN
ES0169501022
SYMBOL
PMRA
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Equity
DENOMINATION
Zeltia
INDEX MEMBERSHIP
-
TRADING SEGMENT
-
TRADING HOURS
07:30:00 AM - 10:00:00 PM
TRADING CURRENCY
Euro
NOMINAL CURRENCY
Euro
SETTLEMENT CURRENCY
Euro
SECTOR AND INDUSTRYHealthcare, Biopharmaceuticals
NUMBER OF SHARES
17.84 Mil.
MARKET CAPITALISATION
792.68 Mil.

Performance overview

1W1M3M6M1Y3Y5YYTD
PERFORMANCE
-1.95 %
8.80 %
-20.59 %
-4.56 %
-4.68 %
122.42 %
1.18 %
0.20 %
HIGH77.0584.15105.00105.00105.00105.00105.00105.00
LOW73.8568.0566.2566.2566.2525.9425.9466.25

Dividende

pro Aktie

Company profile

Pharma Mar SA is a biopharmaceutical holding company, which engages in research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It operates through the following segments: Oncology, Diagnostics, and RNAi. The Oncology segment focuses to the group undertakings whose object is to research, develop, and market anti-tumour drugs. The Diagnostics segment focuses in the development and marketing of diagnostic kits. The RNAi segment develops drugs with therapeutic activity based on reducing or silencing gene expression. The company was founded by José Maria Fernández de Sousa-Faro on April 30, 1986 and is headquartered in Colmenar Viejo, Spain.

Shareholder Structure (Top 10)

AnteilName
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available
N/AInformation Not Available

Analyst Rating

Ø-Target Price DistanceNot Available
Current Price
Not Available
Ø-Target Price
Not Available
Average ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0

Company Events

No company events available.